Falanx Group spikes higher after option deal terms are announced – Proactive Investors UK
stemadminStem Cell BankingNo comments

Falanx Group Limited () added one-fifth to its value at 1.35p as it confirmed executive directors and some senior directors will be making salary sacrifices. As sacrifices go, these are not exactly without some form of compensation; in this case, the persons involved will be offered options over 31.4mln (in aggregate) new shares and warrants covering 1.6mln new shares, To reduce the amount of dilution shareholders might face, this new option pool has been created partly by the waiver of certain share options over 25.7mln shares granted in March and December 2018 to directors and senior managers.

Read more
CareDx Introduces AlloCell: Cell Therapy Surveillance – Global Banking And Finance Review
stemadminStem Cell BankingNo comments

SOUTH SAN FRANCISCO, Calif., April 14, 2020 CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced today a biopharma research partnership for AlloCell. AlloCell is a surveillance solution for patients who have received engineered-cell transplants for allogeneic cell therapy.

Read more
(2020-2025) Cell Banking Outsourcing Market Estimated To Experience A Hike in Growth | Global Industry Size, Growth, Segments, Revenue, Manufacturers…
stemadminStem Cell BankingNo comments

Latest Report onCell Banking Outsourcing Market The report titled Global Cell Banking Outsourcing Market is one of the most comprehensive and important additions to Alexareports archive of market research studies. It offers detailed research and analysis of key aspects of the global Cell Banking Outsourcing market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Cell Banking Outsourcing market.

Read more
Global Stem Cell Banking Market To Drive Swiftly And Reach USD 13.36 Billion By 2025 – Northwest Trail
stemadminStem Cell BankingNo comments

A leading research firm, Zion Market Research added the latest industry report on Stem Cell Banking Market consisting of 110+ pages during the forecast period and Stem Cell Banking Market report offers comprehensive research updates and information related to market growth, demand, opportunities in the global Stem Cell Banking Market.

Read more
ThermoGenesis Holdings Announces That ImmuneCyte Joint Venture Receives $3.0 Million Equity Investment – P&T Community
stemadminStem Cell BankingNo comments

RANCHO CORDOVA, Calif., Jan. 3, 2020 /PRNewswire/ --ThermoGenesis Holdings, Inc.(Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that ImmuneCyte Life Sciences, Inc. ("ImmuneCyte"), an 80/20 joint venture between HealthBanks Biotech (USA) and ThermoGenesis, has closed a $3.0 million equity investment with a private institution

Read more
Vor Biopharma Expands Leadership Team with Chief Legal Officer and Vice President of People – Global Banking And Finance Review
stemadminStem Cell BankingNo comments

Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, today announced two additions to its leadership. Seasoned patent attorney Amy Mendel joins Vor as Chief Legal Officer and human resources executive Tania Philipp joins as Vice President of People. These experienced life sciences specialists continue to round out Vors management team as the company expands, develops its platform technology, and advances its pipeline of eHSC-based therapies.

Read more

Theme: Illdy.